Volume 8, Number 3
Summer, 1999
Pharmacia & Upjohn Renews Glaucoma Research
Fellowship
 |
Pharmacia & Upjohn
Medical Liaison, Ophthalmology, Richard Tyburczy (left) presents
a check to Foundation President Dr. George Spaeth renewing
the Pharmacia & Upjohn Research Fellowship on the Wills Eye
Hospital Glaucoma Service.
Photo by Jamie Nicholl. |
Pharmacia & Upjohn representatives
Paul Chaney (Ophthalmic Business Director, North America), Tom
Ashley (Director of the Medical Science Liaison, Central Nervous
System and Ophthalmology Program), and Richard Tyburczy (Medical
Science Liaison, Ophthalmology), meeting with Wills Eye Hospital
Glaucoma Service Director Dr. George Spaeth on August 26th at
the Hospital, announced the renewal for a second year of the research
fellowship the Company established last year on the Glaucoma Service.
Dr. Jeffrey Henderer, former fellow on the Service and now chief
of the glaucoma unit at the Temple University Medical Center,
was named the new Pharmacia & Upjohn fellow. Dr. Henderer will
conduct his research at Wills Eye Hospital.
Mr. Chaney praised the work
in genetics and "low-tension" glaucoma accomplished by Ordan Lehmann,
the first Pharmacia & Upjohn Glaucoma Fellow. He then took the
opportunity to reaffirm the Company's commitment to glaucoma by
building a bridge between industry and academia, stimulating young
researchers to pursue projects of mutual interest.
In addition to researching
the utility of glaucoma medications such as latanoprost the focus
of the fellowship is also on issues fundamental to treatment:
- the mode of action and efficacy of alternative
treatments
- clinical, economic and humanistic outcomes
of treatments
- tailoring treatments to the needs of individual
patients (for example, through the establishment of ways of
classifying the severity of the disease)
- the impact of new technologies designed
to assess visual function and physiological characteristics
of individual patients
As the new Pharmacia & Upjohn
fellow, Dr. Henderer will be developing an animal model against
which to measure the effectiveness of various therapies for glaucoma.
Also, he will be investigating neuroprotective agents in glaucoma,
agents researchers hope will be able to protect the optic nerve
in glaucoma patients, staving off progression of the disease.
New Fellows on the Glaucoma Service
 |
Clinical Fellow
Richard Ten Hulzen, MD, examines patient Indialee
Palmer. Dr. Ten Hulzer received his medical degree from
and completed his ophthalmology residency as Chief Resident
at the Mayo Medical School in Rochester Minnesota. Says
Dr. Ten Hulzen, "My greatest enjoyment lies in seeing and
caring for patients. My long-term plans will always involve
clinical practice, but I also enjoy teaching." |
 |
Clinical Fellow
Asher Weiner, MD, prepares to see a patient. Born
in Israel, Dr. Weiner completed a residency in ophthalmology
at the Hebrew University and Hadassah Medical School in
Jerusalem. Following a subsequent clinical fellowship in
ophthalmology at Harvard Medical School, Massachusetts Eye
& Ear Infirmary, he completed a second residency in ophthalmology
at St. Luke's Medical Center in Cleveland. In addition to
his clinical and surgical duties, Dr. Weiner is continuing
his research in electroretinography, one of the most exciting
new diagnostic technologies. |
 |
Research Fellow
Mary Lucy Pereira, MD, in the Glaucoma Service research
room. Dr. Pereira was born in and completed her ophthalmology
residency in Rio de Janeiro, Brazil. Dr. Pereira is pursuing
a variety of research projects, including ones focused on
surgical implants in children with glaucoma, the use of
local anesthesia in glaucoma surgery, and the effects of
mitomycin C in combined glaucoma and cataract procedures.
|
Photos by Jamie Nicholl. |
Clinical Fellow
Helen Danesh-Meyer, MD, was born in and completed
her ophthalmology training in New Zealand. Last year she
completed a fellowship on the Neuro-Ophthalmology Service
at Wills Eye Hospital. She plans to return to Australasia
to practice ophthalmology, including dedicated glaucoma
clinics, in an academic setting that involves research,
teaching, and clinical work. |
Glaucoma Patient Support Group Schedule
Sundays 1:30 - 3:30 PM
Wills Eye Hospital Auditorium, 1st Floor
November 14, 1999 - Coping with Advanced
Glaucoma: With Some Comments about Risk Factors
Marlene R. Moster,
MD
December 12, 1999 - General Health
& Glaucoma
Richard P. Wilson,
MD
January 9, 2000 - Understanding Glaucoma
Medications
Elliot Werner, MD
February 13, 2000 - Cataract Surgery
in the Glaucoma Patient
Courtland Schmidt,
MD
March 12, 2000 - Common Sources of
Eye Discomfort in the Glaucoma Patient
Jonathan Myers, MD
April 12, 2000 - Genetics Research
and the Glaucoma Patient
L. Jay Katz, MD
Watch for the 1999 Glaucoma Service Foundation Annual Fund
letter or click here to find out
how you can help now. Your support is crucial as we continue to
work to meet the challenge
of glaucoma through research and education.
|
